Publications

(Displaying in Reverse Chronological Order)

1561
Kumar D, Rohilla RK, Roy N and Rawat DS. Synthesis and antibacterial activity evaluation of unsymmetrically substituted cyclohexane-1,2-diamine derivatives Chemistry & Biology Interface 2011, 1, 263-278.
1562
Kumar H, Kumar R, Grewal BK and Sobhia ME. Insights into the Structural Requirements of PKC?II Inhibitors Based on HQSAR and CoMSIA Analyses Chemical Biology & Drug Design 2011, 78, 283-288.
1563
Kumar H, Shah A and Sobhia ME. Novel insights into the structural requirements for the design of selective and specific aldose reductase inhibitors Journal of Molecular Modeling 2011, 18, 1791-1799.
1564
1565
1566
Kumar L, Baheti A, Mokashi A and Bansal AK. Effect of counterion on the phase behaviour during lyophilization of indomethacin salt forms European Journal of Pharmaceutical Sciences 2011, 44, 136-141.
1567
1568
Kumar S, Kumari N, Singh S, Singh T and Jain S. Doping Studies of Tb (Terbium) and Cu (Copper) on CdSe Nanorods Colloids and Surfaces A: Physicochemical and Engineering Aspects 2011, 389, 5-1.
1569
Kumar V, Khatik GL and Nair VA. Sterically controlled stereo regulations in aldol reactions of 3-aryl-1-alkyl dihydrothiouracils Synlett 2011, 2011, 2997-3001.
1570
Kumar V, Saravanan P, Arvind A and Mohan CG. Identification of hotspot regions of MurB oxidoreductase enzyme using homology modeling, molecular dynamics and molecular docking techniques Journal of Molecular Modeling 2011, 17, 939-953.
1571
1572
Kushwaha S, Vikram A, Trivedi PP and Jena GB. Alkaline, Endo III and FPG modified Comet assay as biomarkers for the detection of oxidative DNA damage in rats with experimentally induced diabetes Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2011, 726, 242-250.
1573
1574
1575
Malik R and Roy I. Making sense of therapeutics using antisense technology Expert Opinion on Drug Discovery 2011, 6, 507-526.